Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
7.43
+0.13 (1.71%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Amneal Pharmaceuticals Employees
Amneal Pharmaceuticals had 8,300 employees as of December 31, 2024. The number of employees increased by 450 or 5.73% compared to the previous year.
Employees
8,300
Change (1Y)
450
Growth (1Y)
5.73%
Revenue / Employee
$336,621
Profits / Employee
-$14,083
Market Cap
2.33B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
AMRX News
- 13 days ago - Amneal Donates $1.5 Million to Support Patients During Parkinson's Awareness Month - Business Wire
- 16 days ago - Amneal to Report First Quarter 2025 Results on May 2, 2025 - Business Wire
- 17 days ago - Amneal Announces New Data from Phase 3 Study Showing Significant Improvements in Sleep Quality with CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Parkinson's Disease - Business Wire
- 21 days ago - Amneal Announces Expanded Coverage for CREXONT® (Carbidopa and Levodopa) to Enhance Access for Parkinson's Disease Patients in the U.S. - Business Wire
- 23 days ago - Amneal Launches BORUZU™, First Ready-to-Use Bortezomib Injection for Multiple Myeloma and Mantle Cell Lymphoma - Business Wire
- 5 weeks ago - Amneal Pharmaceuticals: Shares Still Feel Significantly Undervalued - Seeking Alpha
- 6 weeks ago - Amneal to Participate at Upcoming Investor Conference - Business Wire
- 7 weeks ago - Amneal's BLA Submissions for Two Denosumab Biosimilars Accepted for Review by U.S. FDA - Business Wire